Scopus
YÖKSİS DOI Eşleşti
SJR Q2
Adult living donor liver transplantation from donors with Gilbert’s syndrome: Is it safe?
Clinical Transplantation · Eylül 2020
YÖKSİS Kayıtları
Adult living donor liver transplantation from donors with Gilbert’s syndrome: Is it safe?
Clinical Transplantation · 2020 SCI-Expanded
Prof. Dr. GÖKHAN GÜNGÖR →
YÖKSİS Kayıtları — ISSN Eşleşmesi
The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence
2016 ISSN: 09020063 SCI
Prof. Dr. GÖKHAN GÜNGÖR →
Adult living donor liver transplantation from donors with Gilbert’s syndrome: Is it safe?
2020 ISSN: 0902-0063 SCI-Expanded
Prof. Dr. GÖKHAN GÜNGÖR →
Investigation of the prognostic value of psoas muscle area measurement in pediatric patients before liver transplantation: A single-center retrospective study
2021 ISSN: 0902-0063 SCI-Expanded Q3
Prof. Dr. MEHMET ÖZTÜRK →
Makale Bilgileri
Dergi
Clinical Transplantation
ISSN09020063
Yayın TarihiEylül 2020
Cilt / Sayfa34
Scopus ID2-s2.0-85087911440
Özet
Backgrounds: We evaluate whether it is safe to accept donors with Gilbert's syndrome (GS) for a living donor liver transplantation (LDLT) or not. This study is the first controlled study to be conducted. Methods: Between January 2004 and May 2014, 600 LDLTs which used right lobe liver grafts were performed in our center. Forty-five of the 600 donors had a GS diagnosis. For a control group, 99 donors without GS who had completed 1 year or more of follow-up were selected retrospectively and consecutively. The clinical results of the donors and recipients were then analyzed. Results: A total of 45 donors with GS and 99 donors without GS were included. There were no significant differences in patient demographics, actual graft weight, remnant ratio, portal and ductal variations, pre-peri-post–operative liver enzymes. The donors with GS had significantly higher bilirubin levels compared with the control group at first reading, at maximal peak, and post-operative 1-7 days, 1st and 6th months (P <.001 for all readings). Post-operative complication ratio was 40% in GS, 34.3% in non-GS group. In GS and non-GS group, hospitalization period was 10.2 and 9.2 days, respectively. The 1-year donor survival rate was 100% for both groups and 1-year recipient survival was similar who have donors with GS and non-GS (93.3%; 92.9%, P =.93). Conclusions: The use of right lobe grafts from donors with GS appears to be safe for donor health.
Yazarlar (8)
1
Murat Akyildiz
ORCID: 0000-0002-2080-7528
2
Gökhan Güngör
3
Necdet Guler
ORCID: 0000-0002-5956-7461
4
Sencan Acar
ORCID: 0000-0001-8086-0956
5
Yalcin Erdogan
ORCID: 0000-0002-4159-893X
6
Genco Gencdal
ORCID: 0000-0002-5856-5384
7
Murat Dayangaç
ORCID: 0000-0002-1240-7233
8
Yaman Tokat
ORCID: 0000-0002-9899-1521
Anahtar Kelimeler
donor safety
Gilbert's syndrome
living donor liver transplantation
recipient survival
right hepatectomy
Kurumlar
Florence Nightingale Hospital
Istanbul Turkey
Istanbul Memorial Hospital
Okmeydani Turkey
Koç Üniversitesi
Istanbul Turkey
Sakarya Üniversitesi
Serdivan Turkey
Selçuk Üniversitesi
Selçuklu Turkey
Yeditepe University
Istanbul Turkey
Scimago Dergi (ISSN Eşleşmesi)
Clinical Transplantation
Q2
SJR Skoru0,733
H-Index90
YayıncıWiley-Blackwell Publishing Ltd
ÜlkeUnited Kingdom
Transplantation (Q2)
Metrikler
3
Atıf
8
Yazar
5
Anahtar Kelime